ISOX inhibits HDAC6, leading to a significant reduction in c-Jun N-terminal kinase (JNK) and c-Jun phosphorylation, preceding its inhibitory effect on the growth of glioma cells. This evidence concerns the gene HDAC6 and central nervous system cancer.